Bahram Valamehr, Chief Development Officer at FATE THERAPEUTICS INC (FATE), sold 48,800 shares at $36.93 ($1.8M) on 2020-09-14, disclosed to the SEC on 2020-09-16.
Open-market sale of $1.8M FATE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.65 | 600 | $21K | 1.2% |
| 2 | $36.03 | 16,784 | $605K | 34.1% |
| 3 | $36.03 | 16,784 | $605K | 34.1% |
| 4 | $36.93 | 7,016 | $259K | 14.6% |
| 5 | $36.93 | 7,016 | $259K | 14.6% |
| 6 | $37.49 | 600 |
| $22K |
| 1.3% |
| Total | $36.29 avg | 48,800 | $1.8M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |